Is There More Upside Ahead For Bluebird bio Inc (NASDAQ: BLUE)
Bluebird bio Inc (BLUE) concluded trading on Wednesday at a closing price of $0.49, with 4.27 million shares of worth about $2.09 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -46.24% during that period and on October 30, 2024 the price saw a […]
Some Investing Thoughts On Bluebird bio Inc (NASDAQ: BLUE)
Bluebird bio Inc (BLUE) concluded trading on Wednesday at a closing price of $0.51, with 3.35 million shares of worth about $1.71 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -44.45% during that period and on October 23, 2024 the price saw a […]
Growth Story Still Intact For Bluebird bio Inc (BLUE)
Bluebird bio Inc (BLUE) concluded trading on Wednesday at a closing price of $0.48, with 3.79 million shares of worth about $1.82 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -49.98% during that period and on October 16, 2024 the price saw a […]
Bluebird bio Inc (NASDAQ: BLUE) Loses -77.40% From High. Why That Could Change?
Currently, there are 192.74M common shares owned by the public and among those 189.78M shares have been available to trade. Insiders at the company have transacted a total of 15 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 10 of these insider trades were purchases, […]
Bluebird bio Inc (NASDAQ: BLUE) Hogging The Spotlight Today
Currently, there are 192.74M common shares owned by the public and among those 189.78M shares have been available to trade. Insiders at the company have transacted a total of 15 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 10 of these insider trades were purchases, […]
Bluebird bio Inc (NASDAQ: BLUE) Seen Running Too Hot, Let’s Look At This More Closely
Currently, there are 192.74M common shares owned by the public and among those 187.59M shares have been available to trade. Insiders at the company have transacted a total of 15 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 10 of these insider trades were purchases, […]
Do Bluebird bio Inc (NASDAQ: BLUE) Fit In A Value Investing Philosophy?
Currently, there are 192.74M common shares owned by the public and among those 187.49M shares have been available to trade. Insiders at the company have transacted a total of 15 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 10 of these insider trades were purchases, […]
Bluebird bio Inc (NASDAQ: BLUE) Is Getting Increasingly Hard To Ignore
SSgA Funds Management, Inc. recently announced the acquisition of new stake in Bluebird bio Inc (NASDAQ:BLUE). The institutional investor has increased its shareholding in the Healthcare company by 9.48% to 13.87 million shares with purchase of 1.2 million shares. This fresh investment now brings its stake to 12.67% valued currently at $19.13 million. In addition, […]
Bluebird bio Inc (NASDAQ: BLUE) Is Getting Increasingly Hard To Ignore
BlackRock Fund Advisors recently announced the acquisition of new stake in Bluebird bio Inc (NASDAQ:BLUE). The institutional investor has increased its shareholding in the Healthcare company by 0.89% to 7.81 million shares with purchase of 69040.0 shares. This fresh investment now brings its stake to 7.14% valued currently at $10.78 million. In addition, The Vanguard […]
Bluebird bio Inc (BLUE) Volatility Spurs A Quest For Clarity
With over 11.6 million Bluebird bio Inc (BLUE) shares trading Friday and a closing price of $1.50 on the day, the dollar volume was approximately $17.39 million. The shares have shown a negative half year performance of -50.50% and its price on 01/12/24 gained nearly 8.70%. Currently, there are 192.74M common shares owned by the […]
